A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeng-Yi Wang, MD
Chang Gung Memorial Hospital-Linkuo
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chang Gung Memorial Hospital at Chiayi
Chiayi City, Chiayi Hsien, Taiwan
- Chang Gung Memorial Hospital at Linkou
Linkou District, New Taipei City, Taiwan
- Chang Gung Memorial Hospital at Kaohsiung
Kaohsiung City, Taiwan
- Chang Gung Memorial Hospital at Keelung
Keelung, Taiwan
- Cheng Ching General Hospital
Taichung, Taiwan
- Tri-Service General Hospital
Taipei, Taiwan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2012
- Primary completion
- 30 Apr 2015
- Completion
- 30 Apr 2015
- Last update posted
- 6 Jan 2026
- Registered enrollment
- 221
- Registry id
- NCT02468128
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.